Bookmark and Share

Publications - Books & Chapters

Back to Publications List. 

Levine MM. Immunity to cholera as evaluated in volunteers. In: Nobel Symposium on Cholera and Related Diarrhoeas, 43rd Stockholm, 1978. Cholera and Related Diarrhoeas: Molecular Aspects of a Global Health Problem. Ouchterlony O, Holmgren J (eds.). S Karger, Basel, 1980.

Levine MM, Hornick RB. Immunology of enteric pathogens - Salmonella, Shigella and E. coli. In: Nahmias A, O'Reilly R (eds.). Immunology of Human Infections, Volume 11. Plenum, New York: pp. 249-290, 1981.

Levine MM. Shigellosis. In: Top FH Jr, Wehrle PF, (eds.), Communicable and Infectious Diseases, 9th Edition. St. Louis: Mosby Co., pp. 569-576, 1981.

Levine MM and Cisneros L. Typhoid fever. In: Conn FH (ed.). Current Therapy. Philadelphia: W. B. Saunders Co., 1981

Clements ML, Levine MM. Vibrio cholerae, Escherichia coli, and related diarrheal infections. In: Stanford JP, Luby JP (eds.). The Science and Practice of Clinical Medicine. York: Grune and Stratton, pp.282-287, 1981

Levine MM, Clements ML, Black RE, Hughes TP, Cleaves TF, Oral Rehydration with Simple Sugar/Salt Solutions as an Alternative in Rural Areas when Glucose/Electrolyte Solutions are Unavailable. In: Holme T, Holmgren J (eds.). Acute Enteric Infections in Children: New Prospects for Treatment and Prevention. Elsevier, Amsterdam: pp.325-331, 1981.

Levine MM, Black RE, Clements ML, Nalin DR, Cisneros L, Finkelstein RA, Volunteer studies in development of vaccines against cholera and enterotoxigenic Escherichia coli: a review. In: Holme T, Holmgren J (eds.). Acute Enteric Infections in Children: New Prospects for Treatment and Prevention. Elsevier, Amsterdam: pp.443-459, 1981.

Levine MM. Adhesion of enterotoxigenic Escherichia coli in man and animals. In: Taylor-Robinson D, (ed.). Adhesion and Pathogenicity. Ciba Symposium: pp.142-154, 1981.

Clements ML, Levine MM, Black RE, Treatment of Enteric Infections and Combinations. In: Hitchings GH (ed.). Handbook of Experimental Pharmacology: Sulfonamides, Trimethoprim and Combinations. Springer-Verlag, New York: Chap. 17, pp.357-378, 1982.

Levine MM. Myth and Reality in the Management of Diarrhea. In: Simpson TW, Strickland GT, Mercer MA (eds.). New Developments in Tropical Medicine II. National Council for International Health, Washington, DC, 1983.

Levine MM. Cholera. In: Gellis SS, Kagan GM (eds.). Current Pediatric Therapy, 11th edition. Saunders, Philadelphia: pp. 609-611, 1984.

Levine MM. Vaccine against Escherichia coli infections. In: Germanier R (ed.). Bacterial Vaccines, Chapter 7. New York: Academic Press, pp. 187- 235, 1984.

Formal SB, Levine MM. Shigellosis. In: Germanier R (ed.). Bacterial Vaccines, Chapter 6. Orlando: Academic Press, pp. 167-186, 1984.

Levine MM, Black R, Clements ML, Pathogenesis of Enteric Infections Caused by Vibrio. In: Colwell R (ed.). Vibrios in the Environment, Chapter 7. New York: Academic Press, pp. 109-122, 1984.

Levine MM, Black RE, Clements ML, Young CR, Cheney CP, Schad P, Collins H, Boedeker EC, Prevention of enterotoxigenic Escherichia coli diarrheal infection in man by vaccines that stimulate antiadhesion (anti-pili) immunity. In: Boedecker EC (ed.). Attachment of Organisms to the Gut Mucosa. Boca Raton: CRC Press, pp. 223-244, 1984.

Levine MM. Immunization against infectious diarrhoeas. In: Gracey M (ed.). Diarrhoeal Disease and Malnutrition: A Clinical Update. London: Churchill Livingstone, pp 183-200, 1985.

Kaper JB, Levine MM, Lockman HA, Baldini MM, Black RE, Clements ML, Morris JG. Development and testing of recombinant live oral cholera vaccine. In: Vaccines 85. Molecular and Chemical Basis of Resistance to Parasitic, Bacterial and Viral Diseases. Cold Spring Harbor Laboratories, pp. 107- 111, 1985.

Levine MM, Black RE, Ferreccio C, Clements ML, Lanata C, Rooney J, Chilean Typhoid Committee. The efficacy of attenuated Salmonella typhi oral vaccine strain Ty21a evaluated in controlled field trials. In: Holmgren J, Lindberg A, Mollby E (ed.). Proceedings of the Nobel Conference on Recent Advances in Vaccines and Drugs against Diarrhoeal Diseases, Stockholm, June 3-6, 1985. Student Literatur, Gothenberg, pp. 90-101, 1986.

Levine MM, Morris JG, Losonsky G, Boedeker E, Rowe B, Fimbriae (pili) adhesins as vaccines. In: Lark D, Normak S, Brent-Uhlin E (eds.). Protein-Carbohydrate Interactions in Biological Systems. London: Academic Press, pp. 143-145, 1986.

Levine MM, Kaper JB, Morris JG, Herrington D, Losonsky G, Tall B, Hall R. Reactogenicity, colonizing capacity, and immunogenicity of further attenuated, genetically-engineered Vibrio cholerae 01 vaccine strains. In: Advances in Research of cholera and related diarrheas. Vol 5. Kuwahara S, Pierce NF (eds.). 1986. KTR Scientific Publications, Tokyo.

Levine MM, Black RE, Ferreccio C, Clements ML, Lanata C, Sears S, Morris JG, Cisneros L, Germanier R, Chilean Typhoid Commission. Interventions to control endemic typhoid fever: field studies in Santiago, Chile. PAHO Scientific Publication, Washington, DC, 1986.

Levine MM, Kaper JB, Morris JG, Herrington D, Losonsky G, Tall B, Hall R. Reactogenicity, colonizing capacity, and immunogenicity of further attenuated, genetically-engineered Vibrio cholerae 01 vaccine strains. In: Takeda Y, Sack RB (eds.). Advances in Research of cholera and related diarrheas. Vol 5. Martinus-Nijhoff, The Hague, 1988.

Kaper JB, Lockman HA, Baldini MM, Levine MM. Development of live oral cholera vaccine candidates through recombinant DNA techniques. In: Kuwahara S, Pierce NF (eds.). Advances in Research on Cholera and Related Diarrhoeas, Volume 3. The Hague: Martinus Nijhoff. 1986, 181-191.

Levine MM, Tramont EC, Vaccines against enteric infections. In: Branski D, Pinari G, Rozen P, Walker-Smith J (eds.). Pedriatric Gastroenterology: Aspects of Immunology and Infections. Karger, Basel, pp. 355-369, 1986.

Holmgren J, Svennerholm A-M, Clemens J, Sack D, Black R, Levine M. An oral B subunit-whole cell vaccine against cholera: from concept to successful field trial. In: Meslecky J. (ed.). Proceedings of the International Congress on Mucosal Immunology, Niagara Falls, 1986.

Pierce NF, Cray WC Jr., Kaper JB, Finkelstein RA. Compared colonizing and immunizing abilities of virulent Vibrio cholerae and two avirulent mutants studied in rabbits. In: Kuwahara S, Pierce NF (eds.). Advances in Research on Cholera and Related Diarrhoeas, Volume 3. The Hague: Martinus Nijhoff, 1986, 253-262.

Pierce NF, Kaper JB, Mekalanos JJ, Cray WC, Jr. Determinants of the efficacy of live oral cholera vaccines studied in rabbits. In: Holmgren J, Lindberg A, Mollby R (eds.). Development of Vaccines and Drugs Against Diarrhea, 11th Nobel Conference. Sweden: Studentlitteratur, 1986, 44-52.

Caplan ES, Kotloff KL. The trauma patient. In: The Patient at Risk for Infection. Pennington, JE (ed). 1986, Volume 3.

Levine MM, Black RE, Ferreccio C, Clements ML, Lanata C, Rooney J. Field trials of efficacy of attenuated Salmonella typhi oral vaccine strain Ty21a. In: Robbins JB (ed.). Proceedings of International Symposium on Bacterial Vaccines, Bethesda. New York, Praeger Press, pp. 79-89, 1987.

Levine MM, Herrington DA. Typhoid fever. In: Conn's Current Therapy,1987 edition; Rakel RE (ed.). Philadelphia, W. B. Saunders Co. pp. 107-108.

Kaper JB, Levine MM, Lockman HA, Baldini MM, Black RE, Clements ML, Morris JG. Development of a recombinant live oral cholera vaccine. In: Robbins J, Schneerson R, Klein D, Sadoff J, Hardegree MC (eds.). Bacterial Vaccines. New York: Praeger, 1987, p. 90-97.

Kaper JB, Morris JG, Jr., Nishibuchi M. DNA probes for pathogenic Vibrio species. In: Tenover FC (ed.). DNA Probes for Infectious Disease, Boca Raton, FL: CRC Press. Inc., 1988, 65-77.

Kaper JB and Tacket CO, Applications of Biotechnology to Vaccine Development. In: Pierce G (ed.). Developments in Industrial Microbiology. Society for Industrial Microbiology, J. Microbiology, Vol. 29, Symp. No. 3, 1988, p. 109-118.

Levine MM, Kaper JB, Black RE, Clements ML, Morris JG. Landmarks on the road toward a live oral attenuated cholera vaccine. In: Takeda Y, Kuwahara S (eds.). Vibrio cholerae and Cholera. Tokyo: KTK Scientific Publishers, 1988, 155-161.

Morris JG, Michalski J, Wright AC, Kaper JB, Kaviti JN, Kinoti S, Mohamed AJ, Turkish J, Mhalu FS, Levine MM. Molecular epidemiology of antibiotic-resistant cholera in East Africa. In: Kuwahara S, Pierce NF. (eds.). Advances in Research on Cholera and Related Diarrheas. Vol. 4. The Hague: Martinus Nijhoff, 1988.

Nishibuchi M, Galen JE, Kaper JB. The tdh Gene (Thermostable Direct Hemolysin) Gene of Vibrio parahaemolyticus. In: Kuwahara S, Pierce NF (eds.). Advances in Research on Cholera and Related Diarrhoeas, Volume 4. Tokyo: KTK Scientific Publishers, 1988, 145-157.

Morris JG, Jr., Michalski J, Wright AC, Kaper JB, Kaviti JN, Kinoti S, Mohamed AJ, Turkish J, Mhalu FS, Levine MM. Molecular epidemiology of antibiotic-resistant cholera in East Africa. In: Kuwahara S, Pierce NF (eds.). Advances in Research on Cholera and Related Diarrhoeas, Volume 4. Tokyo: KTK Scientific Publishers, 1988, 17-22.

Levine MM, Kaper JB, Morris JG, Herrington D, Losonsky G, Tall B, Hall R. Reactogenicity, colonizing capacity, and immunogenicity of further attenuated, genetically-engineered Vibrio cholerae 01 vaccine strains. In: Kuwahara S, Pierce NF (eds.). Advances in Research on Cholera and Related Diarrhoeas, Volume 5. Tokyo: KTK Scientific Publishers, 1988, 225-230.

Levine MM, Kaper JB, Black RE, Clements ML, Morris JG. Landmarks on the road toward a live oral attenuated cholera vaccine. In: Kuwahara S, Pierce NF (eds.). Advances in Research on Cholera and Related Diarrhoeas, vol. 4. The Hague: Martinus Nijhoff, 1988.

Morris JG. Foodborne disease: A look at a continuing problem. In: Proceedings of the 65th Agricultural Outlook Conference. U.S. Department of Agriculture, Washington, DC, November 29-December 1, 1988.

Kaper JB and Tacket CO, Recent Advances in Enterotoxigenic, Enterohemorrhagic, and Enteropathogenic Escherichia coli. In: Donachie W, Griffiths E, Stephen J (eds.). Bacterial Infections of Respiratory and Gastrointestinal Mucosa. IRL Press, Vol. 24, 1988, p 113-132.

Nataro JP, Kaper JB, Karch H, Baldini MM, Maher KO, Levine MM. Genetic analysis of virulence plasmids in enteropathogenic E. coli. In: Kuwahara S, Pierce NF (eds.). Advances in Research on Cholera and Related Diarrhoeas, Volume 5. Tokyo: KTK Scientific Publishers, 1988, 151-159.

Sack RB, Kline RL, Spira WM, Kaper JB. Oral immunization of rabbits with enterotoxigenic Escherichia coli protects against intraintestinal challenge, using a modified RITARD model. In: Ohtomo N, Sack RB (eds.). Advances in Research on Cholera and Related Diarrhoeas, Volume 6. Tokyo: KTK Scientific Publishers, 1988, 153-160.

Kaper JB, Mobley HLT, Michalski JM, Herrington DA, Levine MM. Recent advances in developing a safe and effective live oral attenuated Vibrio cholerae vaccine. In: Ohtomo N, Sack RB (eds.). Advances in Research on Cholera and Related Diarrhoeas, Volume 6. Tokyo: KTK Scientific Publishers, 1988, 161-168.

Levine MM. Typhoid fever vaccines. In: Vaccines. Plotkin SA, Mortimer A, Jr. (eds.). Philadelphia, W. B. Saunders Company, pp. 333-361, 1988.

Tacket CO and Rogawski MA. Botulism. In: Lance Simpson (ed.). Botulinum Neurotoxin and Tetanus Toxin, Academic Press, San Diego, CA, 1989, p. 351-378.

Kotloff KL and Rennels MB, Splenomegaly: Infectious etiologies. In: Sills RH, Schwartz AD, Pochedly C (eds.). Disorders of the Spleen. Pathophysiology and Management. New York, Marcel Dekker, Inc, pp 239-264, 1989.

Levine MM, Prado V, Kaper JB, Moseley S, Newland J, Tall B, Baldini MM, Magi L, Gicquelais K, Maher K. DNA probes to detect diarrheagenic Escherichia coli. In: Balows A, Tilton RC, Turano A (eds.). Rapid Methods and Automation in Microbiology and Immunology. Brescia, Italy: Brixia Academic Press, 1989, 420-427.

Kapikian AZ, Flores J, Hoshino Y, Midthun D, Green KY, Gorziglia M, Chanock RM, Potash L, Perez-Schael I, Gonzalez M, Vesikari T, Gothefors L, Wadell G, Glass RI, Levine MM, Rennels MB, Losonsky GA, Christy C, Dolin R, Anderson EL, Belshe RB, Wright PF, Santosham M, Halsey NA, Clements ML, Sears SD, Steinhoff MC, Black RE. Rationale for the development of rotavirus vaccine for infants and young children. In: Talwar (ed.). Progress in Vaccinology. Springer-Verlag, 1989:150-180.

Levine MM, Edelman R. Future vaccines against enteric pathogens. In: Schaffner W (ed.). Immunization in Adults: Infectious Disease Clinics of North America. Philadelphia, W. B. Saunders Co., 1990

Levine MM. Typhoid fever and enteric fever. In: Kass E, Platt R (eds.). Current Therapy in Infectious Diseases. Pennsylvania: BC Decker, 1990:143-145.

Levine MM. Vaccine and vaccination in the historical perspective. In: Woodrow GC, Levine MM (eds.). New Generation Vaccines: The Molecular Approach. New York: Marcel Dekker, 1990:3-19.

Levine MM. Vaccines against enterotoxigenic Escherichia coli infections. In: Woodrow GC, Levine MM (eds.). New Generation Vaccines: The Molecular Approach. New York: Marcel Dekker, 1990:649-660.

Levine MM, Hone D, Stocker B, Cadoz M. New and improved vaccines to prevent typhoid fever. In: Woodrow GC, Levine MM (eds.). New Generation Vaccines: The Molecular Approach. New York: Marcel Dekker, 1990:269-288.

Holmgren JM, Jertborn J, Svennerholm AM, Sack DA, Clemens JD. New and improved vaccines against cholera: the oral B subunit/inactivated whole cell vaccine. In: Woodrow GC, Levine MM (eds.). New Generation Vaccines: The Molecular Approach. New York: Marcel Dekker, 1990:289-303.

Clemens JD, Stanton BF. Longer term evaluation of vaccine efficacy: methodological issues for phase III and phase IV trials. In: Woodrow GC, Levine MM (eds.). New Generation Vaccines: The Molecular Approach. New York: Marcel Dekker, 1990:51-68.

Edelman R, Tacket CO. Adjuvants for AIDS vaccines. In: Koff WC, Kennedy RC (eds.). International Reviews of Immunology: Development of AIDS vaccines. Switzerland: Harwood Academic Publishers, 1990:51-66.

Tacket CO. Vaccines against AIDS. In: Woodrow GC, Levine MM (eds.). New Generation Vaccines: The Molecular Approach. New York: Marcel Dekker, 1990: 741-752.

Herrington DA. Initial clinical evaluation of new vaccine candidates: phase I and phase II trials of safety, immunogenicity, and preliminary efficacy. In: Woodrow, GC, Levine MM (eds.). New Generation Vaccines: The Molecular Approach. New York: Marcel Dekker, 1990:43-48.

Nishibuchi M, Honda T, Miwatani T, Kaper JB. Diversity and possible mobility of the tdh gene of Vibrio parahaemolyticus and related hemolysin genes. In: Takeda Y, Sack RB (eds.). Advances in Research on Cholera and Related Diarrhoeas. Japan: KTK Scientific Publishers, 1990:173-179.

Galen JE, Vimr ER, Lawrisuk L, Kaper JB. Cloning, sequencing and expression of the gene nanH, for Vibrio cholerae neuraminidase. In: Takeda Y, Sack RB (eds.). Advances in Research on Cholera Related Diarrhoeas. Japan: KTK Scientific Publishers, 1990:143-153.

Kaper JB. Vaccines against cholera: attenuated Vibrio cholerae strains prepared by recombinant DNA techniques used as live oral vaccines. In: Woodrow GC, Levine MM (eds.). The Molecular Approach to New and Improved Vaccines. New York: Marcel Dekker, 1990:304-310.

Tacket CO. Vaccines against human enteric Escherichia coli infections. In: SJ Cryz (ed.). Vaccines and Immunotherapy, pp. 86-94.

Aggarwal A, Sadoff J, Kumar S, Hone D, Gross M. Oral Salmonella-malaria CS recombinant vaccine induces CD8+ cytotoxic T cells. In: Vaccines. Cold Spring Harbor Laboratory Press, 1991:381-386.

Kaper JB, Levine MM. Cholera. In: Cryz SJ (ed.). Vaccines and immunotherapy. Pergamon Press, New York, 1991:73-85.

Levine MM. Vaccines against enteric infections. In: Field M (ed.). Diarrheal diseases. Elsevier, New York, 1991:455-484.

Levine MM. Typhoid fever. In: Cryz SJ (ed.). Vaccines and immunotherapy. Pergamon Press, New York, 1991:59-73.

Tacket CO, Clemens J, Kaper JB. Cholera vaccines. In: Ellis RW (ed.). Vaccines: New approaches to immunological problems. Massachusetts: Butterworth-Heinemann, 1991:53-68.

Losonsky GA, Ogra PL. Immunology of the breast and host immunity. In: Polin RA (ed.). Neonatal and fetal medicine: Physiology and Pathophysiology. Philadelphia, W. B. Saunders, 1991:p. 1481.

Serrate SA, Schulof RS, Sztein MB. Current concepts in immunology. In: Principles of Cancer Biotherapy, 2nd Edition. Oldham RK (ed.). Marcel Dekker, New York, NY. 1991. pp 109-131.

Oates KK, Schulof RS, Goldstein AL, Sztein MB. Cancer-associated immune suppression: therapeutic alterations with chemical and biological agents. In: Principles of Cancer Biotherapy, 2nd Edition. Oldham RK. (ed.). Marcel Dekker, New York, NY. 1991. pp. 133-215.

Kotloff KL, Nalin DR. Enteric bacterial infections: general principles. In: Strickland G.T. (ed.). Hunter's Tropical Medicine. W.B. Saunders Co., Philadelphia. 1991. p. 331-340.

Losonsky GA, D'Alessandro de Rimer H. Rotavirus specific breast milk antibody in two populations and possible correlates of protection. In: Mestecky J, Blair C, Ogra PL (eds.). Immunology of Milk and the Neonate in Advances in Experimental Medicine and Biology. 1991;30:265-270.

Kaper JB, Baldini MM. Genetics. In: Barua D and Greenough WB III, eds. Cholera. New York: Plenum Medical Publishers, 1992:69-94.

Kierszenbaum F. and Sztein M. Molecular alterations induced by Trypanosoma cruzi in human lymphocytes which affect cytokine binding and proliferative responses. In: Cytokines and Resistance to Non-Viral Pathogenic Infections. Sonnenfeld, G., Czarniecki, C., Nacy, C., Byrne, G.I. and Degre, M., eds. Biomedical Press. Augusta, GA. 1992. pp. 127-134.

Levine MM, Pierce NF. Immunity and vaccine development. In: Barua D and Greenough WB III, eds. Cholera. New York: Plenum Medical Publishers, 1992:285-327.

Rennels, M. Routine Childhood Immunizations. In: Ambulatory Pediatric Care, 2nd Edition. Ed: Dershewitz, R. 1992, pp. 55-66. Philadelphia, PA, Lippincott Co.

Rennels, M. Yersinia enterocolitica infections. In: Current Pediatric Therapy, 14th Edition. Ed: Burg F., Ingelfinger J., Wald E. 1992. Philadelphia, PA, W.B. Saunders Co.

Savarino S, Levine MM. Specific and non-specific treatment of diarrhea. In: Gorbach SL, Bartlett JG, Blacklow NR, eds. Infectious Diseases. Philadelphia: WB Saunders, 1992:638-646.

Tacket CO, Clemens J, Kaper JB. Cholera vaccines. In: Ellis RW, ed. Vaccines. New Approaches to Immunological Problems. Boston: Butterworth - Heinemann, 1992:53-68.

Hone DM, Tacket CO, Levine MM, Hasday J, Harris AM. Induction of tumor necrosis factor secretion from U937 macrophage-like cells after infection with Salmonella typhi. In: Vaccines 93. 1993 Cold Spring Harbor Laboratory Press, 1993.

Kierszenbaum, F. and Sztein, M.B. Chagas' Disease (American Trypanosomiasis). In: Parasitic Infections and the Immune System. Kierszenbaum, F., ed. Academic Press, Inc. New York, NY. 1994. pp 53-85.

Kohl S, Rennels M, Marks M. Yersinia enterocolitica Infection. In Burg FD, Ingelfinger JR, Wald ER, Polin RA (eds): Current Pediatric Therapy, 15th edition, 1995, pp 589-590, W.B. Saunders Co., Philadelphia, PA.

Scott, D.A., and Edelman, R., Treatment of Gastrointestinal Infections. In: Bailliere's Clinical Gastroenterology. International Practice and Research Vol 7, No2, June 1993. M. Gracey and I. Bouchiere (eds.) London, Bailliere Tindall, W. B. Saunders Co. London.

Levine MM, Kotloff K. Shigellosis. In: Current Pediatric Therapy, 14th edition, Burg FD, Ingelfinger JR, Wald ER, eds., W.B. Saunders Co., Philadelphia, pp.574-575, 1993.

Levine MM. Typhoid fever. In: Current Pediatric Therapy, 14th edition, Burg FD, Ingelfinger JR, Wald ER, eds., W.B. Saunders Co., Philadelphia, pp.575-576, 1993.

Levine MM, Hone DM, Tacket CO, Sztein MB, Losonsky G, Nataro JP, Gonzalez C, Dougan G, Chatfield S, Cryz S, Curtiss R, Kelley S. Attenuated Salmonella typhi as LIve Oral Vaccines to Prevent Typhoid Fever and as Carrier Vaccines to Express Foreign Antigens. In: Biology of Salmonella. Cabello, F., Hormaeche, C., Mastroeni, P. and Bonina, L., eds. Plenum Press. New York, NY. 1993. pp. 343 - 346.

Rennels MB. Yersinia enterocolitica infections. In Burg FD, Ingelfinger JR, Wald ER (eds): Current Pediatric Therapy, 14th edition, 1993, pp 578-579, W.B. Saunders Co., Philadelphia, PA.

Levine MM, Tacket CO. Recombinant live cholera vaccines. In: Vibrio cholerae and Cholera. Wachsmuth IK, Blake P, Olsvik S, eds. Am Soc Micriobiol, Washington, D.C., Chapter 26, pp395-413, 1994.

Levine MM. Typhoid Fever Vaccines. In: Vaccines. Plotkin SA, Mortimer A, Jr., eds. Philadelphia, W.B. Saunders Company, Chapter 21, pp. 597-633, 1994.

Levine MM, Nataro JP. Intestinal infections. In: Mucosal Immunology, Vol.2 Mucosal Diseases. Ogra P, Mestecky J, Lamm M, Strober W, Bienenstock J, McGhee JR, eds.. Academic Press, San Diego, Chapter 41, pp 505-512, 1994.

Levine MM, Giron J, Noriega F. Fimbrial vaccines. In: Fimbriae: Adhesion, Biogenics, Genetics and Vaccines. Klemm P, ed., CRC Press, Boca Raton, Chapter 18, pp 255-276, 1994.

Levine MM and Tacket CO. Recombinant Live Cholera Vaccines, In: Vibrio cholerae and Cholera: Molecular to Global Perspectives, I. Kaye Wachsmuth, Paul A. Blake, and Orjan Olsvik, eds., American Society for Microbiology, Washington, D.C., 1994.

Miller VL, J.B.Kaper JB, Portnoy D, Isberg R, editors. The Molecular Biology of Bacterial Pathogenicity: A Tribute to Stanley Falkow. American Society for Microbiology, Washington D.C., 1994.

Nataro JP, Levine MM. Escherichia coli infections of humans. In: Gyles C, ed. Escherichia coli in Animals. CAB International, Walligford. Chapter 13, pp. 285-335, 1994.

Levine MM, Tacket CO. Recombinant live cholera vaccines. in: Vibrio cholerae and Cholera. Wachsmuth IK, Blake P, Olsvik S, eds. Am Soc Micriobiol, Washington, D.C., Chapter 26, pp 395-413, 1994.

Levine MM, Tacket CO. Live oral vaccines against cholera. In: Ala'Aldeen D, Hormaeche C, eds. Molecular and clinical aspects of bacterial vaccine development. John Wiley & Sons, Chichester, 1995, pp. 233-258.

Levine MM, Savarino S. The treatment of acute diarrhea. Chapter 21. In: Surawicz CMD, Owen RL, eds., Gastrointestinal and Hepatic Infections. W.B. Saunders, Philadelphia, pp 519-536, 1995.

Levine MM, Levine OS. Changes in human ecology and behaviour in relation to the emergence of diarrheal diseases, including cholera. In: Infectious diseases in an age of change. Roizman B, ed. National Academy Press, Washington, D.C., 1995, pp. 31-42.

Levine MM. Non-target effects of live vaccines: myth, reality and demagoguery. In: Non-traget effects of live vaccines. Developments in Biological Standardization vol. 84;33-38, 1995, Karger, Basel.

Rennels MB. Non-typhoidal Salmonellosis. In Burg FD, Ingelfinger JR, Wald ER, Polin RA (eds): Current Pediatric Therapy, 15th edition, 1995, pp 587-588, W.B. Saunders Co., Philadelphia, PA.

Rennels MB. Rotavirus Infection. In Burg FD, Ingelfinger JR, Wald ER, Polin RA (eds): Current Pediatric Therapy, 15th edition, 1995, pp 631-632, W.B. Saunders Co., Philadelphia, PA.

Agin TS, Noel JM, McQueen CE, Boedeker EC, Wolf MK. Host exposure to intimin (Eae) prior to infection with an attaching/effacing rabbit enteropathogen. Is intimin a protective antigen? In: Keusch GT ed, Cytokines and the Gut, IOS Press, Harvard, MA, 1996.

Blake DC, Russell RG, Santini E, Bowen T, Boedeker EC. Pro-inflammatory mucosal cytokine responses to Shiga-like toxin-I (SLT-I): Infection of rabbits with E.coli strain RDEC-H19A. In: Keusch GT ed, Cytokines and the Gut, IOS Press, Harvard, MA, 1996.

Cleghorn F. Human T-cell leukemia Viruses and Associated Diseases, in Textbook of Infectious Diseases, Veronesi, R., (Ed.), Rio de Janeiro, Brazil, 1996.

Kotloff KL. Viral Hepatitis. In: Burg F.D., Ingelfinger J.R., and Wald E.R. (ed), Gellis and Kagan's Current Pediatric Therapy 15. W.B. Saunders Co., Philadelphia, 1996.

Levine MM, Kaper JB. Cholera: pathogenesis and vaccine development. In: Drasar B, Forrest B, eds., Cholera and the Ecology of Cholera. Chapman and Hall, 1996. Chapter 5, pp. 125-186.

Levine MM, Sztein MB. Human Mucosal Vaccines for Salmonella typhi Infections. In: Mucosal Vaccines. H. Kiyono, P.L. Ogra and J.R. McGhee, editors. Academic Press, San Diego, CA. 1996.

Nataro JP, Levine MM. Escherichia coli diseases in humans. In Gyles, C., ed. Escherichia coli infections in humans and animals. 1996.

Mullett C, Acheson D, Bolls C, Tseng L.-Y., Colletton C, Boedeker E. Parenteral Immunization with recombinant B subunit of shiga-like toxin (SLT-1) protects rabbits against inflammation and weight los induced by Escherichia coli strain RDEC-H19A. In: Keusch GT ed, Cytokines and the Gut, IOS Press, Harvard, MA, 1996.

Noriega FR, Formal SB. Vacunas contra Shigella. In: Enfermedades Diarreicas en el Niño. Tenth Edition. L. Torregrosa-Ferráez, J.I. Santos-Preciado, R.S. Rodríguez Suárez, L. Velásquez Jones, J.A. García-Aranda, C.M. Alpuche Aranda, eds. Interamericana/McGraw-Hill. México. pp. 435-439. 1996.

Noriega FR, Levine MM. Vacunas bacterianas. In: Enfermedades Diarreicas en el Niño. Tenth Edition. L. Torregrosa-Ferráez, J.I. Santos-Preciado, R.S. Rodríguez Suárez, L. Velásquez Jones, J.A. García-Aranda, C.M. Alpuche Aranda, eds. Interamericana/McGraw-Hill. México. pp. 430-435. 1996.

Plowe C & Wellems T. Molecular Approaches to the Spreading Problem of Drug Resistant Malaria. In: Antimicrobial Resistance: A Crisis in Health Care, Advances in Experimental Medicine & Biology. Mortensen J (ed.) 1996.

Levine MM, Woodrow GC, Kaper JB and Cobon GS (eds). New Generation Vaccines, 2nd edition. New York: Marcel Dekker, Inc. 1997.

Blattner WA. Human lymphotropic viruses: HTLV-I and HTLV-II. In: Clinical Virology, edited by Richamn, D.D., Whitley, R.J., Hayden, F.G. London: Churchill Livingstone, p. 683-707, 1997.

Blattner WA, O'Brien TR, Mueller N. Human immunodeficiency virus. In: Viral infections of humans: epidemiology and control, edited by Evans, A.S. and Kaslow, R.A. New York: Plenum Press, p. 713-785, 1997.

Cleghorn F, Blattner W. Human T-lymphotropic Viruses Types I and II, in Sexually Transmitted Diseases, Third Edition, Lemon, S. (Ed.), Raven Press, New York, 1997.

Edelman, R. Vaccines Against Lyme Disease. In: New Generation Vaccines, 2nd edition, Levine MM, Woodrow GC, Kaper JP, Coban GS (Eds.) Marcel Dekker, Inc., New York, 1997, p. 897-912.

Edelman, R. Adjuvants for the Future. In: New Generation Vaccines, 2nd edition, Levine MM, Woodrow GC, Kaper JP, Coban GS (Eds.) Marcel Dekker, Inc., New York, 1997, p. 173-192.

Kaper JB, McDaniel TK, Jarvis KG, Gómez-Duarte O. "Genetics of Virulence of Enteropathogenic E. coli (EPEC)" In: Paul, P. S., D. H. Francis, and D. Benfield (eds). Mechanisms in the Pathogenesis of Enteric Diseases. New York: Plenum Publishing Co., 1997, 279-287.

Kaper JB, Tacket CO, Levine MM. Attenuated V. cholerae O1 and O139 Strains as Live Oral Cholera Vaccines. In: MM Levine, Woodrow GC, Kaper JB, Cobon GS. (Eds.), New Generation Vaccines: The Molecular Approach, 2nd Edition, Marcel Dekker, New York, 1997.

Kaper J B, Tacket CO, and M. M. Levine. "Attenuated  V. cholerae O1 and O139 Strains as Live Oral Vaccines". In: Levine, M. M., G. C. Woodrow, J. B. Kaper, and G. S. Cobon (eds). New Generation Vaccines, 2nd eidition. New York: Marcel Dekker, Inc., 1997, 447-458.

Karaolis, D. K. R., T. K. McDaniel, J. B. Kaper, and E. C. Boedeker. "Cloning of the RDEC-1 Locus of Enterocyte Effacement (LEE) and Functional Analysis of the Phenotype on Hep-2 Cells" In: Paul, P. S., D. H. Francis, and D. Benfield (eds). Mechanisms in the Pathogenesis of Enteric Diseases. New York: Plenum Publishing Co., 1997, 241-245.

Kotloff KK, Levine MM. Shigella infections. In: LaMont JT, ed., Gastrointestinal Infections. Diagnosis and Management. Chapter 9, Marcel Dekker, New York, 1997, pp. 265-291.

Kotloff KL, Levine MM. Shigellosis. In Kelley W.N. (ed), Kelley's Textbook of Internal Medicine, Third Edition. J.B. Lippincott, Philadelphia, 1997.

Kotloff KL, Levine MM. Shigella Infections. In LaMont J.T. (ed.), Gastrointestinal Infections. Marcel Dekker, Inc., New York, 1997, pp 265-291.

Levine, MM, Barry EM. Inadvertent Nontarget Effects of Live Vaccines. In: New Generation Vaccines, 2nd edition. M.M. Levine, G.C. Woodrow, J.B. Kaper, and G.S. Cobon Eds., Marcel Dekker Inc., New York, 1997.

Levine MM, Galen JE, Sztein MB, Beier M and Noriega F. Salmonella expressing protozoal antigens. In: New Generation Vaccines. 2nd edition. Myron M. Levine, Graeme C. Woodrow, James B. Kaper and Gary S. Cobon, editors. Marcel Dekker, Inc., New York, N.Y. 1997. pp. 351-361.

Levine MM, Noriega F. Vaccines against diarrheal disease, dysentery and enteric fever. In: Gracey M and Walker-Smith JA, Diarrheal Disease. Nestlé Nutrition Workshop Series volume 38, Lippincott-Raven, Philadelphia, 1997, pp. 139-151

Levine MM, Tacket CO, Galen JE, Barry EM, Chatfield S, Dougan G, Noriega F and Sztein MB. Progress in the development of new attenuated strains of Salmonella typhi as live oral vaccines against typhoid fever. In: New Generation Vaccines. 2nd edition. Myron M. Levine, Graeme C. Woodrow, James B. Kaper and Gary S. Cobon, editors. Marcel Dekker, Inc., New York, N.Y. 1997. pp. 437-446.

Losonsky GA and Levine MM. Enterobacteriacea and Vibrionaceae. Salmonella typhi, Vibrio cholera, Shigella, and diarrheagenic Escherichia coli. In: Manual of Clinical Laboratory Immunology, 5th Edition, ASM Publications, 1997.

Noriega F, Formal SB, Kotloff KL, Lindberg AA. Engineered Attenuated Mutants of Shigella as Live Oral Vaccines. In: MM Levine, Woodrow GC, Kaper JB, Cobon GS (ed.), New Generation Vaccines, 2nd edition. Marcel Dekker, Inc., New York, NY. pp. 853-863. 1997.

Noriega F.R., Lindberg A.A., Formal S.B., Kotloff K. Engineered, Attenuated Mutants of Shigella as Live Oral Vaccines. In Levine M.M., Woodrow G.C., Kaper J.B., Cobon G.S. (eds.), New Generation Vaccines, 2nd edition. Marcel Dekker, Inc., New York, 1997.

Oliver, J.D. and J.B. Kaper. "Vibrio species" In: M.P. Doyle, L.R. Beuchat, and T.J. Montville (eds.) Fundamentals of Food Microbiology. Washington, D.C., ASM Press, 1997, 228-264.

Perry RT, Rennels MB. Campylobacter infections. In Burg FD, Ingelfinger JR, Wald ER, Polin RA (eds) Current Pediatric Therapy, 16th edition, 1997.

Plowe C. Malaria. In: Red Book: Report of the Committee on Infectious Diseases, 24th Ed., American Academy of Pediatrics. Peter, G (ed.) 1997.

Rabkin, C.S., Ward, M.H., Manns, A. and Blattner, W.A. Epidemiology of non-Hodgkin's lymphoma. In: The non-Hodgkin's lymphomas, edited by Magrath, I.T. London: Edward Arnold, p. 171-186, 1997.

Sztein, MB and Mitchell GF. Recent Advances in Immunology: Impact on Vaccine Development. In: New Generation Vaccines. 2nd Edition. Myron M. Levine, Graeme C. Woodrow, James B. Kaper and Gary S. Cobon, editors. Marcel Dekker, Inc., New York, N.Y. 1997. pp. 99-125.

Tacket CO and Levine MM. Vaccines against Enterotoxigenic Escherichia coli Infections. Live Oral Vaccines and Subunit (Purified Fimbriae and Toxin Subunit) Vaccines. In: MM Levine, Woodrow GC, Kaper JB, Cobon GS. (Eds.), New Generation Vaccines: The Molecular Approach. 2nd Edition, Marcel Dekker, New York, 1997.

Tacket CO, Mattheis MJ, Rennels MB. Initial Clinical Evaluation of New Vaccine Candidates. Phase 1 and 2 Clinical Trials of Safety, Immunogenicity, and Preliminary Efficacy. In: MM Levine, Woodrow GC, Kaper JB, Cobon GS. (Eds.), New Generation Vaccines: The Molecular Approach. 2nd Edition, Marcel Dekker, New York, 1997.

Tacket CO, Rennels, MB. Initial clinical evaluation of new vaccine candidates: Phase 1 and 2 clinical trails of safety, immunogenicity and preliminary efficacy in adult and pediatric subjects. In: Levine MM, Woodrow GC, Kaper JB, Cobon GS, (eds): New Generation Vaccines, 2nd edition, Marcel Dekker, Inc. New York, N.Y.,1997, pp 35-46.

Cleghorn FR, Blattner WA. The human T-lymphotropic viruses. In: Sexually Transmitted Diseases, 3rd Edition, McGraw Hill, New York, 1998.

Cleghorn FR, Gallo RC. HIV and HTLV and their relationship to cancer. In: Progress in Cancer Therapy. Blackwell Science Publications, Massachusetts, 1998.

Kaper JB, Gansheroff LJ , Wachtel MR, O’Brien AD. Intimin-mediated adherence of shiga toxin - producing Escherichia coli and attaching-effacing pathogens. In: Kaper JB and O’Brien AD (eds): Escherichia coli O157:H7 and Other Shiga Toxin - Producing E. coli Strains. ASM Press, Washington, D.C., 1998, pp 148-156.

Kaper JB, Elliott S, Sperandio V, Perna NT, Mayhew GF, Blattner FR. Attaching and effacing intestinal histopathology and the locus of enterocyte effacement. In: Kaper JB and O’Brien AD (eds): Escherichia coli O157:H7 and Other Shiga Toxin - Producing E. coli Strains. ASM Press, Washington, D.C., 1998, pp 163-182.

Kaper JB, Elliott SJ, Wainwright LA , Wieler LH, McDaniel TK, and Jarvis KG. The LEE pathogenicity island of enteropathogenic and enterohemorrhagic Escherichia coli. In: Hacker J et al. (eds): Bacterial Protein Toxins. Eighth European Workshop. Gustav Fischer Verlag, Stuttgart, 1998, pp 372-379.

Levine MM. Immunoprophylaxis of Shiga toxin-producing Escherichia coli infection and disease: strengths and weaknesses of various strategies. In: Kaper JB and O’Brien AD (eds): Escherichia coli O157:H7 and other Shiga toxin-producing E. coli strains. ASM Press, Washington, DC, 1998, pp.405-408.

Levine MM. Typhoid fever. In: Evans AS, Brachman PS (eds): Bacterial infections of humans: epidemiology and control, Plenum Medical, New York, 1998, pp 839-858.

Levine MM, Barry EM, Nataro JP, Kaper JB. 1998. The molecular epidemiology of 19th century cholera. In: Greenblatt CL (ed): Digging for Pathogens. Balaban Publishers, Rehovot, Israel, 1998.

Levine M, Barry E, Nataro JP, Kaper JB. Cholera, typhoid, and epidemic Shiga dysentery: emerging infections of the 19th century are re-emerging as we approach the 21st century In: Greenblatt C and Cohen I (eds): Archeology of Emerging Diseases. Balaban Publishers, Rehovot, Israel,1998.

Levine MM and Vial P. Typhoid Fever. In: Current Pediatric Therapy, 16th edition, Burg FD, Ingelfinger JR, Wald ER, Polin RA, eds., W.B. Saunders Co., Philadelphia, pp. 100-101, 1998.

Nataro JP and Levine MM. Enteric bacterial vaccines: Salmonella, Shigella, cholera, Escherichia coli. In: Ogra P, Mestecky J, Lamm M, Strober W, Bienenstock J, McGhee JR (eds): Mucosal Immunology, 2nd ed. Academic Press, San Diego, 1998, pp 851-866.

Nataro JP and Martinez J. Diagnosis and investigation of diarrheagenic E. coli infections. In: Woodford N and Johnson AP (eds): Molecular Bacteriology: Protocols and Clinical Applications. Humana Press, 1998, pp. 387-406.

O'Brien AD and Kaper JB. Shiga toxin -producing Escherichia coli: Yesterday, today, and tomorrow, In: Kaper, J B and O'Brien AD (eds): Escherichia coli O157:H7 and other shiga toxin - producing E. coli strains. ASM Press, Washington, D.C., 1998, pp 1-11.

Trucksis M and , Dunn JP. 1998. Mycobacterial diseases of the eye. In: Jaeger, EA and Tasman W.: Duane’s Foundations of Clinical Ophthalmology. 1998, pp1-8.

Blattner, W.A. Etiology of malignant disease. In: Kelley’s textbook of internal medicine, edited by Kelly, W.N. Philadelphia: J.B. Lippincott, In Press, 1999.

Blattner, W.A. Human retroviruses: their role in cancer. Proc. Am. Assoc. Phys., In Press, 1999.

Blattner, W.A. and Pombo de Oliveira, M.S. Human T-lymphotropic viruses: HTLV-I and HTLV-II. In: Textbook of AIDS medicine, edited by Merigan, T.C.Jr., Bartlett, J.G., and Bolognesi, D. Baltimore: Williams & Wilkins, p. 1003-1029, 1999.

Danella, R.D. and Blattner, W.A. Human T-lymphotropic virus type I/II infection. In: Hunter's Tropical Medicine and Emerging Infectious Diseases. Philadelphia: WB Saunders, p. 192-196, 1999.

Hacker, J. and J. B. Kaper. "The concept of pathogenicity islands" In: J. B. Kaper and J. Hacker (eds). Pathogenicity Islands and Other Mobile Genetic Elements. Washington, D.C.: American Society for Microbiology Press, 1999, 1-11.

Kaper, J. B., J. L. Mellies, and J. P. Nataro. "Pathogenicity islands and other mobile genetic elements of diarrheagenic Escherichia coli" In: J. B. Kaper and J. Hacker (eds). Pathogenicity Islands and Other Mobile Genetic Elements. Washington, D.C.: American Society for Microbiology Press, 1999, 33-58.

Karaolis, D. K. R. and J. B. Kaper "Pathogenicity islands and other mobile virulence elements of Vibrio cholerae" In: J. B. Kaper and J. Hacker (eds). Pathogenicity Islands and Other Mobile Genetic Elements. Washington, D.C.: American Society for Microbiology Press, 1999, 167-187.

Kotloff K.L. Shigellosis. In: Burg F.D., Ingelfinger J.R., and Wald E.R. (ed), Gellis and Kagan's Current Pediatric Therapy 16. W.B. Saunders Co., Philadelphia, 1999, pp 49-51.

Kotloff K.L. Bacterial Diarrheal Pathogens. In Aronoff S.C., Hughes W.T., Kohl S., Wald E.R. (eds.) Pediatric Infectious Diseases. Volume 14. Mosby-Year Book, Inc., St. Louis, 1999, pp 219-268.

Levine MM. Shigellosis. In: Hunter's Tropical Medicine, 8th ed., Strickland GT, ed., W.B. Saunders, Philadelphia, 1999, Chapter 40, pp. 319-323.

Levine MM. Diarrhea caused by Escherichia coli. In: Hunter's Tropical Medicine, 8th ed., Strickland GT, ed., W.B. Saunders, Philadelphia, 1999, Chapter 42, pp. 334-38.

Levine, M., E. Barry, J. P. Nataro, and J. B. Kaper. "The Molecular Epidemiology of 19th Century Cholera" In: C. L. Greenblatt (ed). Digging for Pathogens: Ancient Emerging Diseases - Their Evolutionary, Anthropological and Archaeological Context. Rehovot, Israel: Balaban Publishers, 1998, 265-276.

Nataro, J. P. "Enteric bacterial vaccines: Salmonella, Shigella, Cholera, Escherichia coli". In P. Ogra, ed. Mucosal Immunology, Academic Press, 1999.

Redfield, R.R., Blattner, W.A., and Gallo, R.C. HIV/AIDS at the millennium. In: Textbook of AIDS medicine, edited by Merigan, T.C.Jr., Bartlett, J.G., and Bolognesi, D. Baltimore: Williams & Wilkins, p. 3-9, 1999.

Sarwari AR, Edelman R. Typhoid Fever. In: Conn's Current Therapy, 31st Edition, RE Rakel (Ed.) W. B. Saunders Company, Philadelphia, 1999, p. 163-165.

Fasano A. Bacterial infections: small intestine and colon. Current Opinion in Gastroenterology. 2001, 17:4-9.

Henderson I and Nataro J. Virulence functions of autotransporter proteins. Infection and Immunity. 2001, 69:1231-1243.

DiPierro M, Lu R, Uzzau S, Wang W, Margaretten K, Pazzani C, Maimone F, Fasano. A zonula occludens toxin structure-function analysis. The Journal of Biological Chemistry. 2001, 276:19160-19165.

McClain JB, Edelman R, Shmuklarsky M, Que J, Cryz SJ, Cross AS. Unusual persistence in healthy volunteers and ill patients of hyperimmune immunoglobulin directed agaisnt multiple Pseudomonas O-chain and Klebsiella serotypes after intravenous infusion. Vaccine. 2001, 19:3499-3508.

Darwish MA, Faris R, Darwish N, Shouman A, Gadallah M, El-Sharkawy MS, Edelman R, Grumbach K, Rao MR, Clemens JD. Hepatitis C and cirrhotic liver disease in the Nile Delta of Egypt: a community-based study. American Journal of Tropical Medicine & Hygiene. 2001, 64:147-153.

Waite DC, Jacobson EW, Ennis FA, Edelman R, White B, Kammer R, Anderson C, Kensil CR. Three double-blind, randomized trials evaluating the safety and tolerance of different formulations of the saponin adjuvant QS-21. Vaccine. 2001, 19:3957-3967.

Okeke IN, Edelman R. Dissemination of antibiotic-resistant bacteria across geographic borders. Clinical Infectious Diseases. 2001, 33:364-369.

Drago S, Di Pierro M, Catassi C, Fasano A. Recent developments in the pathogenesis, diagnosis and treatment of celiac disease. Expert Opinion and Therapy Patents. 2002, 12:45-51.